Antipsychotic-induced weight gain is a major management problem for clinicians. It has
been shown that weight gain and obesity lead to increased cardiovascular and …

Objective: To determine effects of physical activity on depressive symptoms (primary
objective), symptoms of schizophrenia, anthropometric measures, aerobic capacity, and …

Objective Development of these guidelines is mandated by the American Association of
Clinical Endocrinologists (AACE) Board of Directors and the American College of …

Objectives: This guideline provides recommendations for the clinical management of
schizophrenia and related disorders for health professionals working in Australia and New …

Abstract The Schizophrenia Patient Outcomes Research Team (PORT) psychosocial
treatment recommendations provide a comprehensive summary of current evidence-based …

Objectives of the study and background Schizophrenia is a complex disease that affects 1%
of the population. This disease has a considerable impact not only on patients' health and …

We aimed to discover whether metabolic complications of schizophrenia (SZ) are present in
first episode (FE) and unmedicated (UM) patients, in comparison with patients established …

Background Proponents of early intervention have argued that outcomes might be improved
if more therapeutic efforts were focused on the early stages of schizophrenia or on people …

Abstract The British Association for Psychopharmacology guidelines specify the scope and
target of treatment for bipolar disorder. The second version, like the first, is based explicitly …

Background Nutrition interventions would appear fundamental for weight management and
cardiometabolic risk reduction in people experiencing severe mental illness (SMI) …